Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersMedical Oncology Physician in Philadelphia, PA
NPI: 1285070490Primary Practice Location
TEMPLE UNIVERSITY HOSPITAL
100 E Lehigh Ave, Philadelphia, PA
Primary Employer
Temple Faculty Oncology Associates
foxchase.org
HQ Phone
Get Marcus's Phone Numberphone_androidMobile
Get Marcus's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 94 | 182 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 50 | 99 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 32 | 32 |
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.
Authors: Julie Vose, Andreas Klein, Yazeed Sawalha, Daniel Landsburg, Francisco Hernandez-Ilizaliturri, Frederick Lansigan, Jason Kaplan, Reem Karmali, James Gerson, Jennifer Anderson, Jennifer Lue, David Inwards, Shalin Kothari, Nishitha Reddy, Bhargavi Pulluri, Veronika Bachanova, Paolo Caimi, Elvira Umyarova, Jennifer Amengual,
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, BIOLOGICAL: Pegfilgrastim, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, DRUG: Dacarbazine, DRUG: Brentuximab Vedotin, PROCEDURE: Computed Tomography, BIOLOGICAL: Filgrastim, DRUG: Vinblastine Sulfate, DRUG: Doxorubicin Hydrochloride
Journal: Blood Adv